Semaglutide
Semaglutide (Rybelsus) is a GLP-1 receptor agonist used for type 2 diabetes. This catalogue lists Rybelsus tablets, an oral form of semaglutide for that use.
Key points
- Acute pancreatitis has been reported in people treated with GLP-1 receptor agonists.
- Persistent, severe abdominal pain is a symptom of acute pancreatitis that people taking semaglutide should know about.
- Semaglutide has not been studied in people with a history of pancreatitis and should be used with caution in this group.
What semaglutide is used for
Semaglutide is a GLP-1 receptor agonist used for Type 2 Diabetes Mellitus. Rybelsus is the single listed brand, supplied as tablets for this use.
Further reading
Related articles
5 Aug 2026 ⋅ 9 min read
Type 2 Diabetes: Why Early Diagnosis Matters More Than It Sounds
Type 2 diabetes symptoms can be mild enough to go unnoticed for years, so it is often diagnosed after complications have already started. What to watch for, what the treatments do, and why more than half of people with diabetes take no medication for it.
Read guide